Observed Signal · Sep 18, 2026 · corporate_event · Source: SEC API · Impact: 2.5/5
8-K Financial Filing Analysis for Okta (2026-09-18)
Okta, Inc. announced changes to its Board of Directors in a Form 8-K filing. Effective September 14, 2026, Emilie Choi resigned as a Class I director without any reported disagreements regarding company operations, policies, or practices. Subsequently, on September 17, 2026, the Board appointed Helen Riley as an independent Class I director and a member of the Audit Committee, effective September 18, 2026, with a term running until the 2027 Annual Meeting of Stockholders. Under Okta's standard non-employee director compensation arrangements, Riley will receive an annual board retainer of $35,000, an additional $13,000 for her Audit Committee service, and an initial grant of 2,907 restricted stock units vesting annually over three years.
The filing reflects routine board refreshment and governance continuity, maintaining independent oversight on the Audit Committee without disruption to core operations.
MARKET SIGNALS
Track Okta Signals & Strategic Shifts
Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.
- Verified primary sources
- Automated briefings
- Instant watchlist setup
Key Takeaways & Evidence Grounding
- Emilie Choi resigned as a Class I director effective September 14, 2026, with no disagreements reported regarding company operations.
- Helen Riley was appointed as an independent Class I director and Audit Committee member effective September 18, 2026, serving until the 2027 Annual Meeting.
- Helen Riley's compensation includes an annual board fee of $35,000, an Audit Committee fee of $13,000, and an initial grant of 2,907 restricted stock units vesting over three years.
Connected Companies & Entities
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Oscar Appoints Three Independent Directors to Board, Expanding Size to Eleven
On November 12, 2026, the Board of Directors of Oscar Health, Inc. appointed Tomer Cohen, Eric Larsen, and Rajat Taneja as independent directors, effective November 13, 2026. In connection with these appointments, the Board expanded its total size from eight to eleven members. Each director will serve until the 2027 annual meeting of stockholders. Additionally, Mr. Cohen joined the Talent and Compensation Committee, while Mr. Taneja joined the Audit Committee and Nominating and Corporate Governance Committee. The newly appointed directors bring significant expertise across technology, consumer product scaling, enterprise security, healthcare advisory, and AI. They will receive standard non-employee director compensation comprising a $70,000 annual cash retainer, committee retainers ranging from $5,000 to $10,000, and initial and annual RSU grants valued at $200,000 each.
8-K Financial Filing Analysis for Kohl's (2026-10-29)
On October 29, 2026, Kohl's Corporation expanded its Board of Directors from eight to nine members and appointed Stacy Taffet as an independent director, effective immediately. Ms. Taffet has been designated to serve on the Board's Audit Committee. Under the Company's Non-Employee Director Compensation Program, she will receive a restricted stock grant on November 13, 2026, with an estimated grant date fair value of $145,000, vesting on the first anniversary of the grant date. The appointment contributes to Kohl's ongoing board refreshment initiatives without introducing any related-party transaction conflicts.
8-K Financial Filing Analysis for UiPath (2026-09-03)
UiPath, Inc. announced comprehensive executive leadership and governance updates effective September 3, 2026. Hitesh Ramani, previously Deputy CFO and Chief Accounting Officer, has been promoted to Chief Financial Officer, allowing Ashim Gupta to focus exclusively on his role as Chief Operating Officer. Concurrently, Brad Brubaker transitioned to Chief Legal & Administrative Officer, and the Board expanded to eight members with the appointment of Kaiser Permanente EVP Yazdi Bagli as an independent director. In addition, CEO Daniel Dines adopted a Rule 10b5-1 trading plan to sell up to 5,000,000 Class A common shares through February 1, 2027.
WATCHLIST & BRIEFINGS
Receive future signals for Okta & competitors in your briefing
Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.
- Regular primary-source checks
- Structured Watchlist briefings
- Preserves current context
Market Signal Monitoring
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
Monitor Okta
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
